|
|
|
|
|
|
|
BIOLOGICAL RESEARCH
|
|
|
|
|
|
Fedorenko O.Yu., Ivanova S.A., Kornetova E.G.(Tomsk) The role of gene polymorphism of the dopamine and glutamate systems in the clinical heterogeneity of schizophrenia and the development of antipsychotic-induced side effects ……………………………………………………………………………………...
|
5
|
|
|
|
|
Shushpanova T.V., Solonsky A.V., Shumilova S.N., Bokhan N.A.(Tomsk) Formation of neuronal elements of the neuroimmune system of the human embryonic brain under the prenatal influence of alcohol ….
|
14
|
|
|
|
|
Boksha I.S., Savushkina O.K., Omelchenko M.A., Prokhorova T.A., Tereshkina E.B., Vorobyeva E.A., Burbaeva G.Sh.(Moscow) Clustering of patients with clinical risk of schizophrenia by platelet biochemical parameters to predict psychopharmacotherapy efficacy ……………………………………………………….
|
23
|
|
|
|
|
Markova E.V., Serenko E.V.(Novosibirsk) Cytokine-mediated mechanisms for the correction of aggressive behavior by in vitro modulated immunocompetent cells ………………………………………………….
|
32
|
|
|
|
|
Vaiman E.E., Tumova M.A., Guseinova Z.T., Khasanova A.K., Efremov I.S., Schneider N.A., Ivanov M.V., Nasyrova R.F. (St. Petersburg, Moscow, Ufa) Influence of single nucleotide polymorphisms of the serotonergic system genes on the occurrence of therapeutic resistance manifestations in patients with schizophrenia …………………………………………………………………………………………………………
|
41
|
|
|
|
|
Zozulya S.A., Popov S.M., Otman I.N., Barkhatova A.N., Klyushnik T.P.(Moscow) Clinical and immunological features in hysterical disorders that form in the structure of endogenous diseases of affective and schizophrenic spectrum ………………………………………………………………………………………...
|
50
|
|
|
|
|
Nikitina V.B., Vetlugina T.P., Lobacheva O.A., Prokopieva V.D., Lebedeva V.F.(Tomsk) Biological markers of the prognosis of the formation, course and effectiveness of therapy for mental disorders and alcohol addiction ……………………………………………………………………………………………………
|
59
|
|
|
|
|
Yazykova A.B., Novoselova A.E., Tsarkov I.E., Zhilyaeva T.V.(Nizhny Novgorod, St. Petersburg) Identification of biomarkers of schizophrenia using mass spectrometry methods (literature review) ……………...
|
71
|
|
|
|
|
Golygina S.E., Tereshkov P.P., Sakharov A.V.(Chita) Blood immune response checkpoints in patients with the first episode of paranoid schizophrenia before therapy (preliminary results) ………………………...
|
82
|
|
|
|
|
Davydova T.V., Vetrile L.A., Zakharova I.A.(Moscow) Antibodies to neurotransmitters ‒ possiblebiomarkers of Alzheimer's disease and depressive disorders ……………………………………………………
|
91
|
|
|
|
|
Idova G.V., Alperina E.L., Zhanaeva S.Ya. (Novosibirsk) The role of T-cell subpopulations in the pathogenesis and therapy of Parkinson's disease (literature review) ……………………………………………….
|
96
|
|
|
|
|
Smirnova K.V., Chizhova N.D., Amstislavskaya T.G.(Новосибирск) Effects of chronic emotional stress on the behavior of mice with Q31L and L100P mutations in the DISC1 gene ……….………………………
|
104
|
|
|
|
|
OBITUARY ……………………………………………………………………………………………………
|
114
|
